Helen I. Torley M.b. Ch. B., M.r.c.p.

Biography

Dr. Helen I. Torley, M.B. Ch. B., M.R.C.P. has been Chief Executive Officer and President of Halozyme Therapeutics, Inc.She was Senior Registrar in rheumatology at the Royal Infirmary, Glasgow, Scotland. Dr. Torley has board significant industry experience and deep knowledge and expertise in development and commercialization of biopharmaceutical products, including several recent successful product launches. She has been a Director of Relypsa, Inc. since January 2015 and Halozyme Therapeutics, Inc. since January 6, 2014. Dr. Torley received her Bachelor of Medicine and Bachelor of Surgery degrees (M.B. Ch.B) from University of Glasgow in 1984 and her MRCP in 1987.

Research Interest

 Medicine and Surgery